MLC and AMLR activate E-rosette negative T-CFC
Tice, D.G.; Reinitz, E.R.
Transplantation Proceedings 21(1 Part 1): 205-207
1989
ISSN/ISBN: 0041-1345 PMID: 2523124 Document Number: 346650
Document emailed within 1 workday
Related Documents
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790Skibiński, G.; Zwoliński, J.; Wieczorek, Z. 1979: Modulation of e rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF) Archivum Immunologiae et Therapiae Experimentalis 27(4): 475-480
Moyito, T.; Aotsuka, S.; Yokohari, R.; Moroi, Y.; Yokohari, R. 1976: Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. a method for detection of circulating immune complexes Ryumachi 16(1): 4-11
Giuliani, S.; Leonardi, E.; Aldovini, D.; Bernardi, D.; Pellegrini, M.; Soli, F.; Ferro, A.; Dalla Palma, P.; Decarli, N.; Barbareschi, M. 2012: Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy Pathologica 104(3): 93-97
Vanoli, M.; Scorza Smeraldi, R.; Fabio, G.; Bonara, P.; Sabbadini, M.G.; Zanussi, C. 1986: AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens Clinical and Experimental Immunology 63(1): 163-170
Hazelton, R.A.; Morrison, J.J.; Vedam, R.; Siskind, V. 1988: Analysis of the responding and stimulating cells in the AMLR of patients with rheumatoid arthritis using limiting dilution Clinical and Experimental Immunology 74(1): 94-99
Lahat, N.; Zelnik, N.; Froom, P.; Kinarty, A.; Etzioni, A. 1988: Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members Clinical and Experimental Immunology 74(1): 32-35
Kato, Y.; Sawada, H.; Tashima, M.; Yumoto, Y.; Okuda, T.; Ueda, T.; Yamagishi, M.; Uchino, H. 1989: Heterogeneous features of Ph-negative CML--possible existence of Ph-negative, bcr-rearrangement-negative CML Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(6): 1004-1012
King, H.W.; Tempest, P.R.; Merrifield, K.R.; Rance, A.J. 1988: Tpr homologues activate met and raf Oncogene 2(6): 617-619
Spits, H.; Cupp, J.; Wrighton, N.; Lee, F.; Hori, T. 1991: Human cd3 negative cd4 negative cd8 negative thymocytes differentiate into cd3 positive cd4 positive cd8 alpha positive beta positive cells in vitro in the presence of il 7 Journal of Cellular Biochemistry Suppl (15 Part F): 59
Knapp, M.T. 1989: Strategies that activate talent Provider 15(11): 7-8
Newman, K.M.; Jean-Claude, J.; Li, H.; Ramey, W.G.; Tilson, M.D. 1994: Cytokines that activate proteolysis are increased in abdominal aortic aneurysms Circulation 90(5 Part 2): II224-II227
Chisholm, G.D. 1989: Treatment of invasive bladder cancer (lymph node negative, metastases negative) Progress in Clinical and Biological Research 303: 559-561
Gatti-Mays, M.E.; Kardon, D.; Chieu, T.T.; Firozvi, K. 2012: Autoimmune pancreatitis in the setting of multifocal Castleman disease in an HIV-negative, HHV-8-negative, 70-year-old man Clinical Advances in Hematology and Oncology: H&o 10(10): 683-686
Masroor, I.; Afzal, S.; Sakhawat, S.; Khan, N.; Beg, M.A.; Kawal, D. 2009: Negative predictive value of mammography and sonography in mastalgia with negative physical findings JPMA. Journal of the Pakistan Medical Association 59(9): 598-601
Martijn, C. Willemsen; Gideon Keren 2002: Negative-based prominence: the role of negative features in matching and choice Organizational Behavior and Human Decision Processes 88(2): 643-666
Norman, J.A.; Staehelin, M. 1982: Calmodulin inhibitors activate glycogen phosphorylase B to a conversion in C6 glioma cells Molecular Pharmacology 22(2): 395-402
Miyauchi, S.; Watanabe, T.; Sasaki, Y.; Takino, R.; Pütz, B. 1996: Voluntary attention to the motion of visually perceived objects can specifically activate either V1 or MT Electroencephalography and Clinical Neurophysiology. Suppl 47: 155-160
Watsky, M.A. 1995: Lysophosphatidic acid, serum, and hyposmolarity activate Cl- currents in corneal keratocytes American Journal of Physiology 269(6 Pt 1): C1385-C1393
Kelleher, D.J.; Dudycz, L.W.; Wright, G.E.; Johnson, G.L. 1986: Ability of guanine nucleotide derivatives to bind and activate bovine transducin Molecular Pharmacology 30(6): 603-608